Pfizer Acquires Pain Drug Maker King for $3.6 Billion

Pfizer Acquires Pain Drug Maker King for $3.6 Billion

JB Reed/Bloomberg

Pfizer has said it is looking to expand its pain products beyond the arthritis treatment Celebrex, seen here.